Atlas FDA

LINX Reflux Management System

FDA premarket approval P100049/S031 · decided 2022-01-07

Approval details

PMA number
P100049
Supplement
S031
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LINX Reflux Management System
Generic name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant
Torax Medical
Date received
2021-12-10
Decision date
2022-01-07
Days to decision
28 days
Decision code
OK30
Product code
LEI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Cincinnati, OH
Statement
Changes regarding DCO 3814 & DCO 3780.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.